Rxwire
In the news · 48h FDA 39 Eli Lilly 19 Roche 9 Merck & Co. (MSD) 8 Johnson & Johnson 4 AbbVie 3 AstraZeneca 3 Novo Nordisk 3
Deals & business · first seen 13h ago, updated 13h ago

Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies

1 outlet CAR-T & cell therapy

Coverage 1 article · 1 outlet

  1. Seeking Alpha Healthcare
    Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies